Extract from the Register of European Patents

EP About this file: EP3287133

EP3287133 - PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  21.02.2020
Database last updated on 27.05.2026
FormerThe patent has been granted
Status updated on  15.03.2019
FormerGrant of patent is intended
Status updated on  27.02.2019
FormerExamination is in progress
Status updated on  03.12.2018
FormerRequest for examination was made
Status updated on  31.08.2018
FormerThe application has been published
Status updated on  26.01.2018
Most recent event   Tooltip03.10.2024Change - lapse in a contracting state
State(s) deleted from list of lapses: AL
published on 06.11.2024  [2024/45]
Applicant(s)For all designated states
Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
[2018/09]
Inventor(s)01 / KLAERNER, Gerrit
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
02 / CONNOR, Eric, F.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
03 / GBUR, Randi, K.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
04 / KADE, Matthew, J.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
05 / KIERSTEAD, Paul, H.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
06 / BUYSSE, Jerry, M.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
07 / COPE, Michael, J.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
08 / BIYANI, Kalpesh, N.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
09 / NGUYEN, Son, H.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
10 / TABAKMAN, Scott, M.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA 94080 / US
 [2019/16]
Former [2018/09]01 / KLAERNER, Gerrit
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
02 / CONNOR, Eric, F.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
03 / GBUR, Randi, K.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
04 / KADE, Matthew, J.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
05 / KIERSTEAD, Paul, H.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
06 / BUYSSE, Jerry, M.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
07 / COPE, Michael, J.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
08 / BIYANI, Kalpesh, N.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, 94080 / US
09 / NGUYEN, Son, H.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
10 / TABAKMAN, Scott, M.
c/o Tricida Inc.
7000 Shoreline Court, Suite 201
South San Francisco, CA California 94080 / US
Representative(s)Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[2018/09]
Application number, filing date17177221.305.06.2014
[2018/09]
Priority number, dateUS201361831445P05.06.2013         Original published format: US 201361831445 P
[2018/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3287133
Date:28.02.2018
Language:EN
[2018/09]
Type: B1 Patent specification 
No.:EP3287133
Date:17.04.2019
Language:EN
[2019/16]
Search report(s)(Supplementary) European search report - dispatched on:EP23.01.2018
ClassificationIPC:A61K31/785, A61P3/12
[2018/09]
CPC:
A61K31/785 (EP,IL,KR,MX,RU,US); A61P3/12 (EP,IL,KR,US); C08F226/02 (EP,IL,KR,MX,US);
C08G73/02 (EP,IL,KR,MX,US); C08G73/024 (EP,IL,KR,MX,US); G01N1/4077 (US);
G01N2001/4083 (US); G01N2001/4088 (US); Y10T428/2982 (EP,MX,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/40]
Former [2018/09]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:PROTONENBINDENDE POLYMERE ZUR ORALEN VERABREICHUNG[2018/09]
English:PROTON-BINDING POLYMERS FOR ORAL ADMINISTRATION[2018/09]
French:POLYMÈRES LIANT LES PROTONS POUR ADMINISTRATION ORALE[2018/09]
Examination procedure21.06.2017Date on which the examining division has become responsible
22.08.2018Amendment by applicant (claims and/or description)
22.08.2018Examination requested  [2018/40]
22.11.2018Despatch of a communication from the examining division (Time limit: M04)
07.01.2019Reply to a communication from the examining division
28.02.2019Communication of intention to grant the patent
11.03.2019Fee for grant paid
11.03.2019Fee for publishing/printing paid
11.03.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP14742001.2  / EP3003327
Divisional application(s)EP19169259.9  / EP3578185
EP20183421.5  / EP3812761
EP25227078.0
Opposition(s)20.01.2020No opposition filed within time limit [2020/13]
Fees paidRenewal fee
21.06.2017Renewal fee patent year 03
21.06.2017Renewal fee patent year 04
27.06.2018Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  Tooltipdeleted
[2024/45]
Former [2022/31]AL17.04.2019
Documents cited:Search[XY] WO2005041902  (ILYPSA INC et al.)
 [Y] US2002159968  (PETERSEN JOHN S et al.)
 [XY] WO2008027551  (GENZYME CORP et al.)
 [XY] WO2008103368  (GENZYME CORP et al.)
 [XY] WO2008011047  (GENZYME CORP et al.)
ExaminationUS2010189679
   S. D. NAVANEETHAN ET AL: "Serum Bicarbonate and Mortality in Stage 3 and Stage 4 Chronic Kidney Disease", CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 6, no. 10, 1 October 2011 (2011-10-01), pages 2395 - 2402, XP055330171, ISSN: 1555-9041, DOI: 10.2215/CJN.03730411

DOI:   http://dx.doi.org/10.2215/CJN.03730411
   BARTON BREZINA ET AL: "Acid loading during treatment with sevelamer hydrochloride: Mechanisms and clinical implications", KIDNEY INTERNATIONAL, vol. 66, no. 90, 1 September 2004 (2004-09-01), LONDON, GB, pages S39 - S45, XP055523207, ISSN: 0085-2538, DOI: 10.1111/j.1523-1755.2004.09007.x

DOI:   http://dx.doi.org/10.1111/j.1523-1755.2004.09007.x
by applicantUS7459502
   AM. J. KIDNEY DIS., vol. 35, 2000, pages 1 - 140
   RAPHAEL, KL; ZHANG, Y; WEI, G ET AL.: "Serum bicarbonate and mortality in adults in NHANES", NEPHROL. DIAL. TRANSPLANT, vol. 28, 2013, pages 1207 - 1213
   LEMAN, J; LITZOW, JR; LENNON, EJ.: "The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis", J. CLIN. INVEST., vol. 45, 1966, pages 1608 - 1614
   FRANCH HA; MITCH WE: "Catabolism in uremia: the impact of metabolic acidosis", J. AM. SOC. NEPHROL., vol. 9, 1998, pages 78 - 81
   BALLMER, PE; MCNURLAN, MA; HULTER, HN ET AL.: "Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans", J. CLIN. INVEST., vol. 95, 1995, pages 39 - 45
   FARWELL, WR; TAYLOR, EN: "Serum anion gap, bicarbonate and biomarkers of inflammation in healthy individuals in a national survey", CMAJ, vol. 182, 2010, pages 137 - 141
   AMERICAN JOURNAL OF KIDNEY DISEASES, vol. 42, 2003, pages S1 - S201
   WIDMER B; GERHARDT RE; HARRINGTON JT; COHEN JJ: "Serum electrolyte and acid base composition: The influence of graded degrees of chronic renal failure", ARCH INTERN MED, vol. 139, 1979, pages 1099 - 1102
   DOBRE M; YANG, W; CHEN J: "Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the chronic renal insufficiency cohort (CRIC) study", AM. J. KIDNEY DIS., vol. 62, 2013, pages 670 - 678
   YAQOOB, MM: "Acidosis and progression of chronic kidney disease", CURR. OPIN. NEPHROL. HYPERTENS., vol. 19, 2010, pages 489 - 492
   JOHNSON RJ, FEEHALLY J: "Comprehensive Clinical Nephrology", 2003, CV MOSBY, article ADROGUE HJ; MADIAS NE: "Respiratory acidosis, respiratory alkalosis, and mixed disorders", pages: 167 - 182
   DUBOSE TD, HAMM LL: "Acid-base and electrolyte disorders: A companion to Brenners and Rectors the Kidney", 2002, WB SAUNDERS, article DUBOSE TD; MACDONALD GA: "renal tubular acidosis", pages: 189 - 206
   GREENBERG A, CHEUNG AK: "Primer on Kidney Diseases", 2005, ELSEVIER-SAUNDERS, article GOLDBERG M: "APPROACH TO ACID-BASE DISORDERS", pages: 104 - 109
   GREENBERG A, CHEUNG AK: "Primer on Kidney Diseases", 2005, ELSEVIER-SAUNDERS, article SZERLIP HM: "Metabolic Acidosis", pages: 74 - 89
   "Clinical practice guidelines for nutrition in chronic renal failure", AM. J. KIDNEY DIS., vol. 35, 2000, pages 51 - 140
   YAQOOB, MM: "Acidosis and progression of chronic kidney disease", CURR. OPIN. NEPHROL. HYPERTEN., vol. 19, 2010, pages 489 - 492
   MITCH WE: "Influence of metabolic acidosis on nutrition", AM. J. KIDNEY DIS., vol. 29, 1997, pages 46 - 48
   DE BRITO-ASHURST !; VARAGUNAM M; RAFTERY MJ ET AL.: "Bicarbonate supplementation slows progression of CKD and improves nutritional status", J. AM. SOC. NEPHROL., vol. 20, 2009, pages 2075 - 2084
   LEMANN J JR; BUSHINSKY DA; HAMM LL: "Bone buffering of acid and base in humans", AM. J. PHYSIOL RENAL PHYSIOL., vol. 5, no. 5, 28 November 2003 (2003-11-28), pages F811 - 32
   LINDENFELD: "HFSA 2010 guidelines", J CARDIAC FAILURE V16 NO 6 P475, 2010
   BREZINA, KIDNEY INT., vol. 66, 2004, pages S39 - S45
   FAN, NEPHROL DIAL TRANSPLANT, vol. 24, 2009, pages 3794
   WRONG, 0 ET AL., CLINICAL SCIENCE, vol. 28, 1965, pages 357 - 375
   STEVENS T; CONWELL DL; ZUCCARO G; VAN LENTE F; KHANDWALA F; PURICH E ET AL.: "Electrolyte composition of endoscopically collected duodenal drainage fluid after synthetic porcine secretin stimulation in healthy subjects", GASTROINTESTINAL ENDOSCOPY, vol. 60, no. 3, 2004, pages 351 - 5, XP004855304, DOI: doi:10.1016/S0016-5107(04)01809-7

DOI:   http://dx.doi.org/10.1016/S0016-5107(04)01809-7
   FORDTRAN J; LOCKLEAR T: "Ionic constituents and osmolality of gastric and small-intestinal fluids after eating", DIGEST DIS SCI., vol. 11, no. 7, 1966, pages 503 - 21
   PHISITKUL S; HACKER C; SIMONI J; TRAN RM; WESSON DE: "Dietary protein causes a decline in the glomerular filtration rate of the remnant kidney mediated by metabolic acidosis and endothelin receptors", KIDNEY INTERNATIONAL., vol. 73, no. 2, 2008, pages 192 - 9
   STEED, JW: "Supramolecular Chemistry", 2009, JOHN WILEY AND SONS, pages: 226
   KIELLAND, J, J. AM. CHEM. SOC., vol. 59, 1937, pages 1675 - 1678
   GENNARO A R: "Remington's Pharmaceutical Sciences, 20th ed.", .
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.